{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:45:57Z","timestamp":1770500757936,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.maturitas.2005.06.017","type":"journal-article","created":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T07:13:06Z","timestamp":1125558786000},"page":"7-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"S1","title":["Identification of risk factors for prevention and early diagnosis of a-symptomatic post-menopausal women"],"prefix":"10.1016","volume":"52","author":[{"given":"Javier","family":"Ferrer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L.","family":"Neyro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Estevez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2005.06.017_bib1","first-page":"1","article-title":"Division of vital statistics. Deaths: final data for 2002","volume":"53","author":"Kochanek","year":"2004","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.maturitas.2005.06.017_bib2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00198-004-1627-0","article-title":"An estimate of the worldwide prevalence, mortality and disability with hip fracture","volume":"15","author":"Johnell","year":"2004","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.maturitas.2005.06.017_bib3","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/hc0702.103727","article-title":"New tools for coronary risk assessment: what are their advantages and limitations?","volume":"105","author":"Pearson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2005.06.017_bib4","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1016\/j.maturitas.2005.06.017_bib5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Prediction of ten year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.maturitas.2005.06.017_bib6","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1515\/CCLM.2004.254","article-title":"The apoB\/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk","volume":"42","author":"Walldius","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.maturitas.2005.06.017_bib7","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1515\/CCLM.2003.214","article-title":"DACH-LIGA Homocysteine e.V. DACH-LIGA homocystein (German, Austrian and Swiss homocysteine society): consensus paper on the rationale use of homocysteine and folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendation","volume":"41","author":"Stanger","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.maturitas.2005.06.017_bib8","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/01.CIR.0000132467.45278.59","article-title":"Should C-reactive protein be added to metabolic syndrome and to assessment of coronary cardiovascular risk","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2005.06.017_bib9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archinte.163.11.1323","article-title":"The value of C-reactive protein in cardiovascular risk prediction: The Rotterdam Study","volume":"163","author":"Van der Meer","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2005.06.017_bib10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1538-7836.2005.01440.x","article-title":"Age-adjusted reference limits for carotid intima-media thickness as better indicator of vascular risk: population-based estimates from the VITA project","volume":"3","author":"Tossetto","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.maturitas.2005.06.017_bib11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.CIR.0000114834.85476.81","article-title":"Evidence-based guidelines for cardiovascular disease prevention in women","volume":"109","author":"Mosca","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2005.06.017_bib12","doi-asserted-by":"crossref","unstructured":"European guideline on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2003;10 (Suppl. 1): S1\u2013S78.","DOI":"10.1097\/01.hjr.0000120621.99766.ef"},{"key":"10.1016\/j.maturitas.2005.06.017_bib13","doi-asserted-by":"crossref","unstructured":"Smtih RE, Saslow D, Sawyers KA, Burke W (for the High Risk Group), Constanza ME (for the Screening Older Women Work Group), Evans III WP (for the mammography Work Group), Foster Jr. RS (for the Physical Examination Work Group), Hendrick E (for the New Technologies Work Group), Eyre HJ, Sener S (for The Breast Cancer Advisory Group). American Cancer Society Guidelines for Breast Cancer Screening: Update 2003. CA Cancer J Clin 2003;53:141\u201369.","DOI":"10.3322\/canjclin.53.3.141"},{"key":"10.1016\/j.maturitas.2005.06.017_bib14","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/jnci\/94.11.844","article-title":"Pretest prediction of BRCA1 or BRCA2 mutation by risk counsellors and the computer model BRCAPRO","volume":"94","author":"Euhus","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2005.06.017_bib15","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2005.06.017_bib16","first-page":"1681","article-title":"Chemoprevention of breast cancer: a joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer","volume":"164","author":"Levine","year":"2001","journal-title":"CMAJ"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2005.06.017_bib17","first-page":"95","article-title":"Breast cancer: hormones and other risk factors","volume":"42","author":"Hulka","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2005.06.017_bib18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/aje\/152.10.950","article-title":"Cumulative risk from breast cancer to age 70 years according to risk factors status: data from the Nurses Health Study","volume":"152","author":"Colditz","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.maturitas.2005.06.017_bib19","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualize probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2005.06.017_bib20","first-page":"333","article-title":"Comparison of two breast cancer risk estimates in women with a family history of breast cancer","volume":"10","author":"Mc Tiernan","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.maturitas.2005.06.017_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","article-title":"Autosomal dominant inheritance of early onset breast cancer: implications for risk prediction","volume":"73","author":"Claus","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2005.06.017_bib22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jama.1995.03520310075033","article-title":"Assessment and counselling for women with a family history of breast cancer. A guide for clinician","volume":"273","author":"Hoskins","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2005.06.017_bib23","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/jnci\/94.11.844","article-title":"Pretest prediction of BRCA1 or BRCA2 mutation by risk counsellors and the computer model BRCAPRO","volume":"94","author":"Euhus","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2005.06.017_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA 2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am J Hum Gen"},{"key":"10.1016\/j.maturitas.2005.06.017_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jnci\/89.3.227","article-title":"Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 and BRCA2 based on family history","volume":"89","author":"Berry","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2005.06.017_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(98)04394-3","article-title":"Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomized women. Italian Prevention Study","volume":"352","author":"Veronesi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2005.06.017_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(98)85012-5","article-title":"Interim analysis of breast cancer incidence in the Royal Marsden Hospital tamoxifen randomised chemo prevention trial","volume":"352","author":"Powles","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2005.06.017_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-137-1-200207020-00017","article-title":"Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force","volume":"137","author":"Kinsinger","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2005.06.017_bib29","unstructured":"U.S.Prevention Services Task Force (USPSTF). Recommendation and rationales. Chemoprevention of Breast Cancer, www.ahrq.gov\/clinic\/3duspstf\/brreastchemo\/breastchemorr.htm."},{"key":"10.1016\/j.maturitas.2005.06.017_bib30","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in post-menopausal women: results from MORE randomised trail. Multiples outcomes of Raloxifene evaluation","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2005.06.017_bib31","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing outcomes relevant to Evista: breast cancer incidence in post-menopausal osteoporotic women in a randomised trial of raloxifene","volume":"96","author":"Martino","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2005.06.017_bib32","doi-asserted-by":"crossref","unstructured":"Martino S, Cauley JA, Barrett-Connor E, et al. CORE Investigators. Incidence of invasive breast cancer following 8 years of raloxifene therapy in post-menopausal women with osteoporosis: results from the Continuing Outcmes Relevant to Evista (CORE) trial. J Clin Oncol, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), vol. 22, no. 14S (July 14, Supplement); 2004. p. 1000.","DOI":"10.1200\/jco.2004.22.90140.1000"},{"key":"10.1016\/j.maturitas.2005.06.017_bib33","doi-asserted-by":"crossref","unstructured":"Cauley JA, Martino S, Barrett-Connor E, et al. CORE Investigators. Effect of raloxifene on invasive breast cancer incidence in post-menopausal women stratified by Gail risk assessment: results of the Continuing Outcomes Relevant to Evista (Core) trial. J Clin Oncol, 2004 ASCO Annual Meeting Proceedings (Post-Meeting edition), vol. 22, No. 14S (July 15 Supplement); 2004. p. 1018.","DOI":"10.1200\/jco.2004.22.90140.1018"},{"key":"10.1016\/j.maturitas.2005.06.017_bib34","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1503\/cmaj.1030757","article-title":"Canadian Task Force on Preventive Health Care. Prevention of osteoporosis and osteoporotic fractures in post-menopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care","volume":"170","author":"Cheung","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.maturitas.2005.06.017_bib35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1359\/jbmr.2000.15.4.710","article-title":"Risk factors for longitudinal bone loss in elderly men and women: The Framingham Osteoporosis Study","volume":"15","author":"Hannan","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2005.06.017_bib36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factor for hip fracture in white women. Study of Osteoporotic Fractures Research Group","volume":"332","author":"Cumming","year":"1995","journal-title":"N Engl Med"},{"key":"10.1016\/j.maturitas.2005.06.017_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00198-002-1317-8","article-title":"Determinants of incident vertebral fractures in men and women: results from the European Prospective Study (EPOS)","volume":"14","author":"Roy","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2005.06.017_bib38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s001980200078","article-title":"Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture. The EPIDOS prospective study","volume":"13","author":"Dargent-Molina","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2005.06.017_bib39","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1359\/jbmr.2002.17.7.1237","article-title":"International variations in hip fracture probabilities: implication for risk assessment","volume":"17","author":"Kanis","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2005.06.017_bib40","unstructured":"National Osteoporosis Foundation. Physicians Guide to prevention and treatment of osteoporosis; 2003. http:\/\/www.nof.org\/physguide\/inside_cover.htm."},{"key":"10.1016\/j.maturitas.2005.06.017_bib41","doi-asserted-by":"crossref","unstructured":"Management of post-menopausal osteoporosis: position statement of The North American Menopause Society. Menopause 2002;9:84\u2013101.","DOI":"10.1097\/00042192-200203000-00003"},{"key":"10.1016\/j.maturitas.2005.06.017_bib42","unstructured":"The Canadian Consensus Conference on Menopause and Osteoporosis 2002 Update. The Society of Obstetrician and Gynaecologists of Canada, p. 1\u201388, http:\/\/www.sogc.medical.org\/COGCnet\/sogc_doca\/common\/\/guide\/pdfs\/osteoMeno.pdf."},{"key":"10.1016\/j.maturitas.2005.06.017_bib43","doi-asserted-by":"crossref","unstructured":"U.S. Preventive Services Task Force. Screening for Osteoporosis in Post-menopausal Women. Ann Intern Med 2002;137:526\u201328.","DOI":"10.7326\/0003-4819-137-6-200209170-00014"},{"key":"10.1016\/j.maturitas.2005.06.017_bib44","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Management of osteoporosis. A National Clinical Guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN) (SIGN publication; no. 71); 2003. 45p."},{"key":"10.1016\/j.maturitas.2005.06.017_bib45","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4158\/EP.9.6.544","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of post-menopausal osteoporosis: 2001 edition, with selected updates for 203","volume":"9","author":"Hodgson","year":"2003","journal-title":"Endocr Pract"},{"key":"10.1016\/j.maturitas.2005.06.017_bib46","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1359\/jbmr.1999.14.5.821","article-title":"Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures","volume":"14","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2005.06.017_bib47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s001980050099","article-title":"Family history and risk of osteoporotic fracture","volume":"8","author":"Fox","year":"1998","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2005.06.017_bib48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1359\/jbmr.2000.15.4.710","article-title":"Risk factors for longitudinal bone loss in elderly men and women. The Framingham Osteoporosis Study","volume":"15","author":"Hannan","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2005.06.017_bib49","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1001\/archinte.1990.00390230093012","article-title":"Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy","volume":"150","author":"Reid","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2005.06.017_bib50","first-page":"1289","article-title":"Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry","volume":"162","author":"Cadarette","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/j.maturitas.2005.06.017_bib51","first-page":"37","article-title":"Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density","volume":"4","author":"Lydick","year":"1998","journal-title":"Am J Mang Care"},{"key":"10.1016\/j.maturitas.2005.06.017_bib52","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s001980170072","article-title":"An assessment tool for predicting fracture risk in post-menopausal women","volume":"12","author":"Black","year":"2001","journal-title":"Osteoporos Int"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512205001908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512205001908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:41:12Z","timestamp":1759912872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512205001908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":52,"alternative-id":["S0378512205001908"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2005.06.017","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of risk factors for prevention and early diagnosis of a-symptomatic post-menopausal women","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2005.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}